Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
Immunoglobulin light chain - Wikipedia
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Mechanisms of Light Chain Injury along the Tubular Nephron | American Society of Nephrology
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone - Kidney International
Immunoglobulin Light Chain - an overview | ScienceDirect Topics
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
Structure of a normal immunoglobulin (Ig) molecule. Each immunoglobulin... | Download Scientific Diagram
Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
The biology of immunoglobulin free light chains and kidney injury - Kidney International
Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the Literature - Clinical Lymphoma, Myeloma and Leukemia
Two cases of multiple myeloma, presenting with light-chain tubulopathy
Full article: Comparing domain interactions within antibody Fabs with kappa and lambda light chains
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy